Cargando…

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

BACKGROUND: An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use. This presents a potential risk to established treatments for opioid use disorder (i.e., medications for opi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Cayley, Law, Justine, Imtiaz, Sameer, Rehm, Jürgen, Le Foll, Bernard, Ali, Farihah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433668/ https://www.ncbi.nlm.nih.gov/pubmed/37587456 http://dx.doi.org/10.1186/s13722-023-00402-0

Ejemplares similares

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2021)

Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse
por: Ali, Farihah, et al.
Publicado: (2022)

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data
por: Imtiaz, Sameer, et al.
Publicado: (2021)

Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review
por: Banka-Cullen, Sonam Prakashini, et al.
Publicado: (2023)

Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD)
por: Mills, Rosalina, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada
por: Ali, Farihah, et al.
Publicado: (2021)

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study()
por: Russell, Cayley, et al.
Publicado: (2021)

Corrigendum to “Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study” [Journal of Substance Abuse Treatment 129 (2021) 108374]
por: Russell, Cayley, et al.
Publicado: (2021)

Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study
por: Ali, Farihah, et al.
Publicado: (2023)

“2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit
por: Ali, Farihah, et al.
Publicado: (2023)

Harms of prescription opioid use in the United States
por: Imtiaz, Sameer, et al.
Publicado: (2014)

“You’re Not Supposed to be on it Forever”: Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids
por: Dickson-Gomez, Julia, et al.
Publicado: (2022)

The impact of prescription opioids on all-cause mortality in Canada
por: Imtiaz, Sameer, et al.
Publicado: (2016)

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program
por: Reed, Megan K., et al.
Publicado: (2023)

Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
por: Eugenia Socias, M., et al.
Publicado: (2023)

Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model
por: Cloutier, Renee M., et al.
Publicado: (2023)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study
por: Livingston, Nicholas A., et al.
Publicado: (2022)

Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2019)

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
por: Russell, Cayley, et al.
Publicado: (2022)

Application of the multiphase optimisation strategy (MOST) to optimise HIV prevention targeting people on medication for opioid use disorder (MOUD) who have cognitive dysfunction: protocol for a MOST study
por: Mistler, Colleen B, et al.
Publicado: (2023)

Microbial community succession and their relationship with the flavor formation during the natural fermentation of Mouding sufu
por: Chen, Zhongai, et al.
Publicado: (2023)

A Scoping Review on Cue Reactivity in Methamphetamine Use Disorder
por: Seow, Lee Seng Esmond, et al.
Publicado: (2020)

Urinary retention concomitant with methamphetamine use: a case report
por: Ojo, Ayotunde Olumide, et al.
Publicado: (2021)

Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario
por: Loheswaran, Genane, et al.
Publicado: (2015)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map
por: Zolopa, Camille, et al.
Publicado: (2022)

Recent changes in trends of opioid overdose deaths in North America
por: Imtiaz, Sameer, et al.
Publicado: (2020)

Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study
por: Edsall, Andrew, et al.
Publicado: (2021)

Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care
por: Haggerty, Treah, et al.
Publicado: (2022)

Types of suicide pacts: a comparative analysis using the National Violent Death Reporting System
por: Kim, Kawon Victoria, et al.
Publicado: (2023)

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities
por: Korthuis, P. Todd, et al.
Publicado: (2022)

Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: a retrospective cohort study
por: Martin, Rosemarie A., et al.
Publicado: (2022)

A narrative review of alcohol consumption as a risk factor for global burden of disease
por: Rehm, Jürgen, et al.
Publicado: (2016)

Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study
por: Samokhvalov, Andriy V., et al.
Publicado: (2018)

Histone modifications in cocaine, methamphetamine and opioids
por: Cheng, Junzhe, et al.
Publicado: (2023)

Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study
por: Ali, Farihah, et al.
Publicado: (2023)

The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
por: Frost, Madeline C., et al.
Publicado: (2021)

Identifying the Factors Affecting Methamphetamine Use: A Scoping Review
por: Rastegari, Azam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iml61nret8j03h71e5qob1n7m7